Ardea Sued Over $1.3B AstraZeneca Deal
By Sindhu Sundar ( April 24, 2012, 10:39 PM EDT) -- AstraZeneca PLC and Ardea Biosciences Inc. were hit with a lawsuit Monday by a proposed class of Ardea investors claiming that the British pharmaceutical giant's $1.3 billion purchase price for California-based Ardea undervalues the company....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.